Targeted protein degradation has moved well beyond its prologue more than 20 years ago. 1 The number of publications describing different PROTACs (PROteolysis TArgeting Chimeras), molecular glues, and ...

Targeted protein degradation has opened up a new field of drug discovery with potential to treat previously ‘undruggable’ diseases Dundee researchers have revealed new levels of details of how protein ...

Protein kinases are the molecular switches of the cell. They control growth, division, communication, and survival by attaching phosphate groups to other proteins. When these switches are stuck in the ...

Targeted protein degraders (TPDs) are found in the lighter weight divisions of therapetuic development. But even though these therapeutic contenders qualify as small-molecule agents, they pack a big ...

Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded ...

Anti-tumor activity of TAK-659, a dual inhibitor of SYK and FLT-3 kinases, in AML models. Relation of the BIM deletion polymorphism to intrinsic EGFR-TKI resistance of Chinese patients with EGFR ...

SINGAPORE--(BUSINESS WIRE)--Albatroz Therapeutics, a biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, today announced it has secured $3 million USD in ...

Caption A degron-fused protein of interest is recognized for rapid degradation by a TIR1 mutant only in the presence of an auxin analog, which initiates the degradation process. The target protein is ...

Molecular glues are small, monovalent molecules that reshape an E3 ubiquitin ligase (E3) surface to promote a new protein-protein interaction with a target, triggering ubiquitination and removal by ...